The reverse side of the victory: Flare up of symptoms after discontinuation of sunitinib or sorafenib in renal cell cancer patients. A report of three cases

By Desar Ingrid   Mulder Sasja   Stillebroer Alexander   van Spronsen Dick-Johan   van der Graaf Winette   Mulders Peter   van Herpen Carla  

Acta Oncologica, Vol. 48, Iss. 6, 2009-08 ,pp. : 927-931

Informa Healthcare

Access to resources Recommend Favorite

Response to alectinib after one year of discontinuation of crizotinib in anaplastic lymphoma kinase-positive non-small-cell lung cancer: A case report

By                  

Molecular and Clinical Oncology, Vol. 3, Iss. 4, 2015-01 ,pp. : 889-891

Science Publishers

Access to resources Recommend Favorite

Patient-reported lower urinary tract symptoms, urinary incontinence, and quality of life after external beam radiotherapy for localized prostate cancer –– 15 years’’ follow-up. A comparison with age-matched controls

By Fransson Per  

Acta Oncologica, Vol. 47, Iss. 5, 2008-03 ,pp. : 852-861

Informa Healthcare

Access to resources Recommend Favorite

Disease Flare After EGFR Tyrosine Kinase Inhibitor Cessation Predicts Poor Survival in Patients with Non-small Cell Lung Cancer

By Chen Hua-Jun   Yan Hong-Hong   Yang Jin-Ji   Chen Zhi-Hong   Su Jian   Zhang Xu-Chao   Wu Yi-Long  

Pathology & Oncology Research, Vol. 19, Iss. 4, 2013-10 ,pp. : 833-838

Springer Publishing Company

Access to resources Recommend Favorite

Prolonged survival of a patient with lung cancer after treatment with S-1, a new oral fluoropyrimidine anticancer drug

By Urata Yoshiko   Negoro Shunichi   Satouchi Miyako   Kurata Takayasu   Yoshimura Sho   Shimada Temiko   Takada Yoshiki  

Medical Oncology, Vol. 24, Iss. 1, 2007-01 ,pp. : 103-107

Humana Press, Inc

Access to resources Recommend Favorite